ASLAN Pharmaceuticals Limited (ASLN)
July 26, 2024 - ASLAN Pharmaceuticals Limited was delisted.
0.6000
-0.1000 (-14.27%)
Inactive · Last trade price on Jul 18, 2024

ASLAN Pharmaceuticals Stock Forecast

ASLN's stock price has decreased by -97.15% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for ASLAN Pharmaceuticals stock had an average target of 90.67, with a low estimate of 72 and a high estimate of 120.

Price Target: $90.67 (+15011.67%)
Analyst Consensus: Strong Buy
No price target forecast data available
TargetLowAverageMedianHigh
Price$72$90.67$80$120
Change+11900.0%+15011.7%+13233.3%+19900.0%
* Price targets were last updated on May 3, 2024.

Analyst Ratings

The average analyst rating for ASLAN Pharmaceuticals stock from 3 stock analysts was "Strong Buy". This means that analysts believed this stock was likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy222222
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$72
Strong BuyReiterates$72+11,900.00%May 3, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$72
Strong BuyReiterates$72+11,900.00%Apr 23, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$72
Strong BuyReiterates$72+11,900.00%Apr 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$136$72
Strong BuyMaintains$136$72+11,900.00%Mar 18, 2024
Piper Sandler
Piper Sandler
Buy
Reiterates
$120$80
BuyReiterates$120$80+13,233.33%Mar 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 12.00M
Revenue Next Year
n/a
EPS This Year
-3.41
from -22.00
EPS Next Year
-2.40
from -3.41
Year2019202020212022202320242025
Revenue
3.00M---12.00M--
Revenue Growth
-------
EPS
-58.00-16.00-20.00-30.00-22.00-3.41-2.40
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20242025
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20242025
High--
Avg--
Low--

EPS Forecast

EPS20242025
High-3.51-2.47
Avg-3.41-2.40
Low-3.27-2.30

EPS Growth

EPS Growth20242025
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.